Skip to main content

. 1964 Jul;43(7):1486–1494. doi: 10.1172/JCI105025

The Effect of 6-Azauridine Administration on De Novo Pyrimidine Production in Chronic Myelogenous Leukemia^{^*}

V H Bono Jr ¹, S M Weissman ¹, E Frei III ¹

PMCID: PMC289625 PMID: 14192530

1486

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

CARDOSO S. S., CALABRESI P., HANDSCHUMACHER R. E. Alterations in human pyrimidine metabolism as a result of therapy with 6-azauridine. Cancer Res. 1961 Dec;21:1551–1556. [PubMed] [Google Scholar]
EISEN A. Z., WEISSMAN S., KARON M. Pseudouridine metabolism. I. Isolation and the effect of diet on urinary excretion. J Lab Clin Med. 1962 Apr;59:620–629. [PubMed] [Google Scholar]
FALLON H. J., FREI E., 3rd, BLOCK J., SEEGMILLER J. E. The uricosuria and orotic aciduria induced by 6-azauridine. J Clin Invest. 1961 Oct;40:1906–1914. doi: 10.1172/JCI104415. [DOI] [PMC free article] [PubMed] [Google Scholar]
HANDSCHUMACHER R. E., CALABRESI P., WELCH A. D., BONO V., FALLON H., FREI E., 3rd Summary of current information on 6-azauridine. Cancer Chemother Rep. 1962 Aug;21:1–18. [PubMed] [Google Scholar]
HANDSCHUMACHER R. E. Orotidylic acid decarboxylase: inhibition studies with azauridine 5'-phosphate. J Biol Chem. 1960 Oct;235:2917–2919. [PubMed] [Google Scholar]
KALOUSEK F., RYCHLIK I., SORM F. Inhibition of formation of the acceptor sequence pCpCpA in soluble ribonucleic acid by 6-azauridine-5'-diphosphate. Biochim Biophys Acta. 1962 Sep 17;61:368–372. doi: 10.1016/0926-6550(62)90137-8. [DOI] [PubMed] [Google Scholar]
NATHAN D. G., DAVIDSON J. D., WAGGONER J. G., BERLIN N. I. The counting of barium carbonate in a liquid scintillation spectrometer. J Lab Clin Med. 1958 Dec;52(6):915–917. [PubMed] [Google Scholar]
OLIVERIO V. T., DENHAM C., DAVIDSON J. D. Oxygen flask combustion in determination of C-14 and H3 in biological materials. Anal Biochem. 1962 Aug;4:188–189. doi: 10.1016/0003-2697(62)90035-0. [DOI] [PubMed] [Google Scholar]
PASTERNAK C. A., HANDSCHUMACHER R. E. The biochemical activity of 6-azauridine: interference with pyrimidine metabolism in transplantable mouse tumors. J Biol Chem. 1959 Nov;234:2992–2997. [PubMed] [Google Scholar]
RABKIN M. T., FREDERICK E. W., LOTZ M., SMITH L. H., Jr Pyrimidine metabolism in man. V. The measurement in vivo of the biochemical effect of antineoplastic agents in animal and human subjects. J Clin Invest. 1962 Apr;41:871–883. doi: 10.1172/JCI104544. [DOI] [PMC free article] [PubMed] [Google Scholar]
SMITH L. H., Jr, BAKER F. A. Pyrimidine metabolism in man. I. The biosynthesis of orotic acid. J Clin Invest. 1959 May;38(5):798–809. doi: 10.1172/JCI103862. [DOI] [PMC free article] [PubMed] [Google Scholar]
WEISSMAN S. M., EISEN A. Z., FALLON H., LEWIS M., KARON M. The metabolism of ring-labeled orotic acid in man. J Clin Invest. 1962 Jul;41:1546–1552. doi: 10.1172/JCI104611. [DOI] [PMC free article] [PubMed] [Google Scholar]
WEISSMAN S., BONO V. H., Jr, LEWIS M. METABOLIC INERTNESS OF OROTIDINE IN MAN AND THE RAT. Proc Soc Exp Biol Med. 1963 Dec;114:682–685. doi: 10.3181/00379727-114-28769. [DOI] [PubMed] [Google Scholar]
WEISSMAN S., EISEN A. Z., KARON M. Pseudouridine metabolism. II. Urinary excretion in gout, psoriasis, leukemia, and heterozygous oroticaciduria. J Lab Clin Med. 1962 May;59:852–858. [PubMed] [Google Scholar]

ACTIONS

RESOURCES